The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: A report from the MRC Paediatric and Adult Working Parties

Leukemia

Volumn 12, Issue 4, 1998, Pages 463-473

  Chessells, J M ^a   Hall, E ^b   Prentice, H G ^c   Durrant, J ^d   Bailey, C C ^e   Richards, S M ^f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ICRF ^*

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Northern and Yorkshire Region

^f RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Lymphoblastic leukaemia; Prognosis; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PATIENT COMPLIANCE; PHILADELPHIA 1 CHROMOSOME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 0031978626     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400959     Document Type: Article

References (19)

1. Hoelzer D, Thiel E, Loffler H, Bodenstein H, Plaumann L, Buchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Muller U, Wendt F-C, Sodomann H, Ruhl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken C, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fulle H, Mitrou PS, Pfreundschuh M, Gorg C, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, Konig H, Mainzer K, Herrmann R, Messerer D, Zwingers T. Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 1984; 64: 38-47.
2. Reiter A, Schrappe M, Ludwig W-D, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Diethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients, results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
3. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet 1995; 345: 143-148.
4. Prentice HG, Durrant IJ, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia; results of UK Medical Research Council randomised trial UKALL XA. Br J Haematol 1997; 99: 84-92.
5. Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII: report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood. Br J Haematol 1991; 78: 187-196.
6. Durrant IJ, Richards SM. Results of the Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia. Br J Haematol 1993; 85: 84-92.
7. Bleyer WA, Coccia PF, Sather HN, Level C, Lukens J, Niebbugge DJ, Siegel S, Littman PS, Leikin SL, Miller DR, Chard RL, Hammond DG and Childrens Cancer Study Group. Reduction in central nervous system leukaemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. J Clin Oncol 1983; 1: 317-325.
8. Chessells JM, Bailey C, Wheeler K, Richards SM. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet 1992; 340: 565-568.
9. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237-2251.
10. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 1977; 35: 1-39.
11. Cox D. The contribution of statistical methods to cancer research. Cancer 1991; 67: 2428-2430.
12. Hoelzer D. Therapy and prognostic factors in adult acute lymphoblastic leukaemia. Baillières Clin Haematol 1994; 7: 299-320.
13. Proctor SJ. Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach. Br J Haematol 1994; 88: 229-233.
14. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
15. Steinherz PC, Siegel SE, Bleyer WA, Kersey J, Chard R Jr, Coccia P, Leikin S, Lukens J, Neerhout R, Nesbit M, Miller DR, Reaman G, Sather H, Hammond D. Lymphomatous presentation of childhood acute lymphoblastic leukemia: a subgroup at high risk of early treatment failure. Cancer 1991; 68: 751-758.
16. Crist W, Shuster J, Look T, Borowitz M, Behm F, Bowman P, Frankel L, Pullen J, Krance P, Steuber P, Camitta B, Amylon M, Link M, Land V. Current results of studies of immunophenotype-, age-and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia 1992; 6: 162-166.
17. Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol 1995; 89: 364-372.
18. Seeker-Walker LM, Chessells JM, Stewart EL, Swansbury GJ, Richards S, Lawler SD. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol 1989; 72: 336-342.
19. Whitehead VM, Vuchich MJ, Lauer SJ, Mahoney D, Carroll AJ, Shuster JJ, Esseltine DW, Payment C, Look AT, Akabutu J, Bowen T, Taylor LD, Camitta B, Pullen DJ. Accumulation of high levels of metholrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1992; 80: 1316-1323.